As of 2025-09-18, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 14.5x | 13.6x |
| Forward P/E multiples | 16.4x - 34.0x | 19.2x |
| Fair Price | (23.78) - (20.74) | (23.71) |
| Upside | -162.2% - -154.3% | -162.0% |
| Date | EV/EBITDA |